Background: Hepatitis B virus (HBV) infection is one of the most important global health problems and active immunization is the single most important and effective preventive measure against HBV infection. Several studied show that HBV carrier rate is between 2% - 7% in Bangladesh. Bangladesh introduced hepatitis B vaccination in children through Expanded Program on Immunization (EPI) in 2005 that includes 3 doses which starts from six weeks after birth. Currently booster vaccination is not recommended any more. However, many studies on different countries observed a declined level of HBs-antibody over a period of 3 - 6 years that may even reach to non-protective levels. Objective: To evaluate the status of seroconversion and seroprotection along with non-responders of EPI vaccinated children against HBV and to measure their antibody levels in different age groups. Methods: A cross sectional descriptive study was done in the department of Pediatric Gastroenterology, Hepatology & Nutrition, Dhaka Shishu (Children) Hospital, Dhaka, Bangladesh on 120 cases of EPI vaccinated children enrolled from January-December 2019 while attending the inpatient department without any liver problem. The development of Anti-HBs titre greater than or equal to 10 mIU/mL is considered as protective immunity and any titre less than 10 mIU/mL as non-protective following HBV vaccination. Results: Age of the children was 1 - 12 years with mean age of 5.6 ± 1.7 years and male: female ratio was 1.1:1. Among the children, 56 (46.6%) were from 1 - 5 years age, 36 (30.1%) children from 6 - 10 years age group and 27 (23.3%) children from 11 - 12 years age group. Out of 120 children, presence of Anti-HBs protective titre was in 63 (52.5%) children and non-protective level in 57 (47.5%) children. Among protective level, 34 (60.7%) children were in 1 - 5 years age group, 18 (50.0%) children in 6 - 10 years age group and 11 (39.3%) children in 11 - 12 years age group. Total 24 (20%) children were completely non-responder (antibody titre 0.00 mIU/mL). Out of 120 mother, 06 (5%) were HBV positive. Among them 05 (83.33%) children had Anti-HBs less than 10 mIU/mL. Conclusion: After primary vaccination, a good immune response was detected against hepatitis B virus but it goes below even up to non-protective level with the increase of age. Half of the studied children had non-protective titre after 5 years and one-fifth children totally non-responder after primary hepatitis B vaccination. A booster dose
References
[1]
World Health Organization (2017) Guidelines on Hepatitis B and C Testing. WHO, Geneva, 1-204.
[2]
World Health Organization (2015) Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. WHO, Geneva, 1-166.
[3]
Mahmud, S., Rahman, M., Tasneem, F., Afroz, M., Ahmed, S.S. and Hussain, M. (2017) Surface Antigen (HBsAg) Negative Hepatitis B Virus in Bangladesh: Warrants the Screening for Blood Donors. Bangladesh Journal of Child Health, 41, 181-188. https://doi.org/10.3329/bjch.v41i3.36954
[4]
World Health Organization (2019) HBV Key Facts. Geneva.
[5]
World Health Organization (2017) Hepatitis B Vaccines: WHO Position Paper. 369-392.
[6]
Zaman, M.H., Rahman, A. and Yasmin, M. (2018) Epidemiology of Hepatitis B Virus Infection in Bangladesh: Prevalence among General Population, Risk Groups and Genotype Distribution. Genes, 9, 1-16. https://doi.org/10.3390/genes9110541
[7]
Hossain, M.M., Alam, A.N., Siddiqua, M., Siddika, A. and Nessa, A. (2018) Immune Response among the Children to Hepatitis B Vaccination: A Community Based Study in Bangladesh. Bangladesh Medical Research Council Bulletin, 44, 103-108. https://doi.org/10.3329/bmrcb.v44i2.38705
[8]
Bruce, M.G., Bruden, D., Hurlburt, D., Zanis, C., Thompson, G., Rea, L., et al. (2016) Antibody Levels and Protection after Hepatitis B Vaccine: Results of a 30-Year Follow-Up Study and Response to a Booster Dose. The Journal of Infectious Diseases, 214, 16-22. https://doi.org/10.1093/infdis/jiv748
[9]
WHO Position Paper on Hepatitis B Vaccines. http://www.who.int/wer/2009/wer8440.pdf
[10]
Mohamad, M., Mazahi, E.I., Hussein, M., Maksoud, H.M.A., Hady, M.A., Ali, M.A., et al. (2016) Long Term Immunity to Hepatitis B Vaccine among a Sample of Secondary School Students in Damietta. Journal of Pharmacology and Toxicology, 11, 27-32. https://doi.org/10.3923/jpt.2016.27.32
[11]
Yazdanpanah, B., Safari, M. and Yazdanpanah, S. (2010) Persistence of HBV Vaccine’s Protection and Response to Hepatitis B Booster Immunization in 5- to 7-Year-Old Children in the Kohgiloyeh and Boyerahmad Province, Iran. Hepatitis Monthly, 10, 17-21.
[12]
World Health Organization (2011) The Immunological Basis of Immunization Series. Module 22: Hepatitis B. 1-30.
[13]
Mahmood, S., Shah, K.U. and Khan, T.M. (2018) Immune Persistence after Infant Hepatitis-B Vaccination: A Systemic Review and Meta-Analysis. Scientific Reports, 8, Article No. 12550. https://doi.org/10.1038/s41598-018-30512-8
[14]
Khan, T.M. (2006) Evaluation of Immune Status against Hepatitis B Following Hepatitis B Vaccination under EPI Programme.
[15]
Freitas, D.A., Motta, M.S., Mussi-Pinhata, M.M., Jorge, S.M., Yoshida, C.F.T. and Souza, C.B.S. (2002) Immunogenicity of Hepatitis B Vaccine in Preterm and Full-Term Infants Vaccinated within the First Week of Life. Vaccine, 20, 1557-1562. https://doi.org/10.1016/S0264-410X(01)00493-5
[16]
Perera, J., Perera, B. and Gamage, S. (2002) Seroconversion after Hepatitis B Vaccination in Healthy Young Adults, and the Effect of a Booster Dose. Ceylon Medical Journal, 47, 6-8. https://doi.org/10.4038/cmj.v47i1.6396
[17]
Dassah, S., Sakyi, S.A., Frempong, M.T., Luuse, A., Ephraim, R.K.D., Anto, E.O., et al. (2015) Seroconversion of Hepatitis B Vaccine in Young Children in the Kassena Nankana District of Ghana: A Cross Sectional Study. PLoS ONE, 10, e0145209. https://doi.org/10.1371/journal.pone.0145209
[18]
Lee, K.H., Shim, K.S., Lim, I.S., Chae, S.A., Yun, S.W., Lee, N.M., et al. (2017) Changes in Hepatitis B Virus Antibody Titres Overtime among Children: A Single Center Study from 2012 to 2015 in an Urban of South Korea. BMC Pediatrics, 17, 1-8. https://doi.org/10.1186/s12887-017-0924-7
[19]
Alssamei, F.A.A., Sonboli, N.A., Alkumaim, F.A., Alsayaad, N.S., Ahdal, M.S., Higazi, T.B., et al. (2017) Assessment of Immunization to Hepatitis B Vaccine among Children under 5 Years in Rural Areas of Taiz, Yemen. Hepatitis Research and Treatment, 2017, Article ID: 2131627. https://doi.org/10.1155/2017/2131627
[20]
Yue, X., Ge, C., Zhuge, S., He, H., Yang, H., Xu, H., et al. (2017) Changes and Analysis of Anti-HBs Titres after Primary Immunization in 1 to 16 Year Old Chinese Children: A Hospital Based Study. Journal of Viral Hepatitis, 25, 373-380. https://doi.org/10.1111/jvh.12818
[21]
Qawasmi, M., Samuh, M., Glebe, D., Gerlich, W.H. and Azzeh, M. (2015) Age-Dependent Decrease of Anti-HBs Titers and Effect of Booster Doses Using 2 Different Vaccines in Palestinian Children Vaccinated in Early Childhood. Human Vaccines & Immunotherapeutics, 11, 1717-1724. https://doi.org/10.1080/21645515.2015.1041687
[22]
Zhao, Y.L., Han, B.H., Zhang, X.J., Pan, L.L., Zhou, H.S., Gao, Z., et al. (2019) Immune Persistence 17 to 20 Years after Primary Vaccination with Recombination Hepatitis B Vaccine (CHO) and the Effect of Booster Dose Vaccination. BMC Infectious Diseases, 19, 482. https://doi.org/10.1186/s12879-019-4134-9
[23]
Rezaei, M., Nooripoor, S., Ghorbani, R., Ramezanshams, F., Mamishi, S. and Mahmoudi, S. (2014) Seroprotection after Hepatitis B Vaccination in Children Aged 1 to 15 Years in Central Province of Iran, Semnan. Journal of Preventive Medicine and Hygiene, 55, 1-3.
[24]
Norizuki, M., Kitamura, T., Komada, K., Sugiyama, M., Mizokami, M., Xeuatvongsa, A., et al. (2019) Serologic Testing of Randomly Selected Children after Hepatitis B Vaccination: A Cross-Sectional Population-Based Study in Lao People’s Democratic Republic. BMC Infectious Diseases, 19, 507. https://doi.org/10.1186/s12879-019-4086-0
[25]
Pileggi, C., Papadopoli, R., Bianco, A. and Pavia, M. (2017) Hepatitis B Vaccine and the Need for a Booster Dose after Primary Vaccination. Vaccine, 35, 6302-6307. https://doi.org/10.1016/j.vaccine.2017.09.076
[26]
Hummel, I.B., Huber, B., Wenzel, J.J. and Jilg, W. (2016) Markers of Protection in Children and Adolescents Six to Fourteen Years after Primary Hepatitis B Vaccination in Real Life. The Pediatric Infectious Disease Journal, 35, 286-291. https://doi.org/10.1097/INF.0000000000000994
